WVEWave Life Sciences Ltd.
What is the market doing?
No clear lean: nothing decisive, though in a downtrend (−62% vs 200-day).
In a downtrend, below its 50- and 200-day averages. Oversold (RSI 25). Price is −62% vs its 200-day average.
Insiders were net sellers over the 90 days ending Oct 8, 2026; selling is often routine (taxes, diversification).
Heavily shorted, settled Sep 15, 2026, about a week of normal trading to cover. Up 8.3% since the previous count, down from 9.1% of shares outstanding three months ago.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How WVE is trading
Wave Life Sciences Ltd. is −50% over the past year while the S&P 500 is +18%: 68 points behind the market.
1-year return · S&P 500 +18%
- vs 200-day average
- −62%
vs 200-day average · a clear downtrend
- RSI (14)
- 25
RSI (14) · oversold, sold harder than it has been bought
- Below its 52-week high
- 84%
Below its 52-week high
Details›
- Last close2026-10-09
- $3.47
- 1 monthS&P 500 +2.7%
- −26%
- 1 yearS&P 500 +18%
- −50%
- 5 yearsS&P 500 +88%
- −37%
- vs 50-day average$4.76
- −27%
- 52-week high
- $21.31
- 52-week low
- $3.46
- Annualised volatility
- 144%
| Year | Return |
|---|---|
| 2026 (year to date) | −80% |
| 2025 | +37% |
| 2024 | +145% |
| 2023 | −28% |
| 2022 | +123% |
| 2021 | −60% |
| 2020 | −1.9% |
| 2019 | −81% |
| 2018 | +20% |
| 2017 | +34% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 3 of 10 | −7.4% |
| Feb | 10 | 7 of 10 | +6.4% |
| Mar | 10 | 3 of 10 | −13% |
| Apr | 10 | 2 of 10 | −7.9% |
| May | 10 | 4 of 10 | −2.3% |
| Jun | 10 | 4 of 10 | +9.4% |
| Jul | 11 | 6 of 11 | +1.1% |
| Aug | 11 | 8 of 11 | +14% |
| Sep | 11 | 4 of 11 | −0.05% |
| Oct | 11 | 5 of 11 | +9.9% |
| Nov | 10 | 6 of 10 | +10.0% |
| Dec | 10 | 2 of 10 | +1.1% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.